Economic burden of irritable bowel syndrome in China

doi:10.3748/wjg.v22.i47.10450

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 47

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9063)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-8) series.

Item

Count

PDF

528

WORD

238

HTML

5519

Tables (1-8)

209

Sum=6494

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

846

Download

1705

Sum=2551

Dec 21, 2016 (publication date) through Aug 31, 2024

Times Cited of This Article

Times Cited (59)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Dec 21, 2016; 22(47): 10450-10460
Published online Dec 21, 2016. doi: 10.3748/wjg.v22.i47.10450

Table 7 Total costs of four irritable bowel syndrome subtypes (CNY yuan)

	IBS-C	IBS-D	IBS-M	IBS-U	P value
Direct medical costs	12036.72 (10319.41-13841.58)	12838.55 (11570.90-14221.77)	12990.03 (11094.74-14757.98)	13127.30 (11484.21-14680.82)	0.830
Direct nonmedical costs	973.31 (741.98-1252.00)	812.15 (586.09-1114.49)	986.80 (95.42-201.77)	863.34 (716.92-1025.52)	0.792
Indirect costs	4449.10 (4020.92-4893.99)	4890.66 (4648.80-5169.87)	4914.35 (4446.81-5340.35)	4308.71 (4017.27-4584.88)	0.031¹
Total costs	17459.12 (15369.32-19486.61)	18541.36 (17241.44-19933.29)	18891.18 (16960.86-20813.44)	18299.35 (16423.33-20269.52)	0.817

¹There was significant difference between indirect costs of irritable bowel syndrome-constipation (IBS-C) vs IBS-diarrhea (IBS-D) vs IBS-mixed (IBS-M) vs IBS-unclassified (IBS-U) (P = 0.031).

Citation: Zhang F, Xiang W, Li CY, Li SC. Economic burden of irritable bowel syndrome in China. World J Gastroenterol 2016; 22(47): 10450-10460
URL: https://www.wjgnet.com/1007-9327/full/v22/i47/10450.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i47.10450